IRIS
CACCIOLA, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.625
NA - Nord America 1.490
AS - Asia 649
SA - Sud America 419
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 4.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.475
IE - Irlanda 492
SE - Svezia 413
BR - Brasile 387
IT - Italia 331
SG - Singapore 271
CN - Cina 256
DE - Germania 97
UA - Ucraina 65
FI - Finlandia 53
PL - Polonia 39
GB - Regno Unito 33
BE - Belgio 27
IN - India 27
FR - Francia 16
HK - Hong Kong 16
AR - Argentina 15
RU - Federazione Russa 15
TR - Turchia 11
AT - Austria 10
ID - Indonesia 10
UZ - Uzbekistan 9
BD - Bangladesh 7
MA - Marocco 7
ZA - Sudafrica 7
EC - Ecuador 6
NL - Olanda 6
CL - Cile 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
VN - Vietnam 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GR - Grecia 4
KE - Kenya 4
MX - Messico 4
CA - Canada 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
LB - Libano 3
MD - Moldavia 3
NO - Norvegia 3
PA - Panama 3
PK - Pakistan 3
SN - Senegal 3
CO - Colombia 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
LT - Lituania 2
NZ - Nuova Zelanda 2
TG - Togo 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
MY - Malesia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.219
Salva come PNG Salva come JPEG
Città #
Dublin 492
Chandler 294
Nyköping 279
Singapore 172
Messina 155
Jacksonville 146
Beijing 84
Ashburn 77
Ann Arbor 75
Princeton 67
Medford 62
Des Moines 50
Dearborn 44
Cambridge 40
Warsaw 31
Boardman 29
Los Angeles 29
São Paulo 28
Brussels 24
Jinan 24
The Dalles 24
Munich 19
Rosolini 19
Woodbridge 19
Helsinki 17
Hong Kong 16
Rio de Janeiro 16
Nanjing 15
Nuremberg 15
Rome 15
Hyderabad 14
New York 14
Belo Horizonte 13
San Mateo 12
Wilmington 12
Catania 11
Hebei 11
Seattle 11
Jakarta 10
Pune 10
Shenyang 10
Avola 9
Houston 9
Tianjin 9
Haikou 8
Bremen 7
Guangzhou 7
Pachino 7
Vienna 7
Brasília 6
Düsseldorf 6
Hangzhou 6
Porto Alegre 6
Shanghai 6
Tashkent 6
Changsha 5
Fuzhou 5
Palermo 5
São José dos Campos 5
Taizhou 5
Zhengzhou 5
Amsterdam 4
Athens 4
Baghdad 4
Baku 4
Brno 4
Curitiba 4
Dong Ket 4
Falls Church 4
Fortaleza 4
Frankfurt am Main 4
Guayaquil 4
Hefei 4
Jaú 4
Nairobi 4
Nanchang 4
Radomsko 4
Ribeirão Preto 4
Águas Lindas de Goiás 4
Ankara 3
Antwerp 3
Auburn Hills 3
Betim 3
Caltagirone 3
Casablanca 3
Cotia 3
Dakar 3
Diadema 3
Jacareí 3
Jequié 3
Joinville 3
Lanzhou 3
Montes Claros 3
New Haven 3
Ningbo 3
Osasco 3
Palhoça 3
Praia Grande 3
Qingdao 3
Recife 3
Totale 2.769
Salva come PNG Salva come JPEG
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 130
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 121
Atrial fibrillation in patients with cirrhosis 115
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 98
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 97
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 96
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 92
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 84
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 80
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 79
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 79
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 79
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 77
Oscillazione dei livelli di viremia in soggetti portatori cromici asintomatici di infezione da virus B. Dati preliminari 77
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 76
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 75
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 75
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 73
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 73
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 71
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 70
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 70
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 69
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 69
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 68
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 68
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 67
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 66
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 66
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 66
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 65
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience 64
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 63
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 63
Oscillazione dei livelli di viremia in soggetti portatori cronici asintomatici di infezione da virus b. Dati preliminari 62
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 60
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 60
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 59
PREVALENCE OF BACTERIAL RESISTANCE IN CIRRHOTIC PATIENTS WITH BACTERIAL INFECTION: A PRELIMINARY REPORT 59
Erectile dysfunction in compensated liver cirrhosis 59
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 58
Fever and rhomboid target lesion in decompensated cirrhosis 58
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 57
Strain endocardico longitudinale tra pazienti cirrotici di classe A e B al punteggio di Child-Pugh 56
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 55
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 55
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 54
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 54
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 53
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 52
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 52
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. 51
Dermatiti iatrogene in corso di trattamento dell’epatopatia HCV-correlata con simeprevir 50
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 48
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 48
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 47
Occult hepatitis B virus infection 44
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 42
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 41
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 40
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 39
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 37
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 37
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 34
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 34
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 32
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 29
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 27
null 22
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 20
null 20
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 16
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 14
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 9
Totale 4.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020139 0 0 0 0 0 0 0 0 0 81 51 7
2020/2021408 35 4 84 16 48 30 21 48 39 45 22 16
2021/2022481 13 53 14 14 36 4 52 11 7 66 65 146
2022/20231.347 81 162 73 89 86 127 32 77 556 7 37 20
2023/2024340 27 61 20 36 31 44 7 10 3 44 18 39
2024/20251.206 30 27 44 118 77 71 83 326 378 52 0 0
Totale 4.425